Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

7.69
Delayed Data
As of 10:18am ET
 -0.075 / -0.97%
Today’s Change
7.42
Today|||52-Week Range
15.49
-0.32%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close7.76
Today’s open7.69
Day’s range7.65 - 7.87
Volume11,132
Average volume (3 months)164,453
Market cap$287.8M
Dividend yield--
Data as of 10:18am ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-68.05%
Earnings growth (this year)-14.20%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.53%
P/E ratioNM
Price/Sales26.13
Price/Book65.81

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.03-0.39%
ARLZAralez Pharmaceutica...-0.05-1.14%
CRVSCorvus Pharmaceutica...+0.16+1.13%
MNKDMannKind Corp+0.00+0.42%
Data as of 10:34am ET, 01/23/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$25.9M
Annual profit (last year)-$85.4M
Net profit margin-329.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts


Search for Jobs